Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.10.0.1
Consolidated Balance Sheets - USD ($)
Sep. 30, 2018
Sep. 30, 2017
Current Assets:    
Cash $ 30,896 $ 1,348
Total current assets 30,896 1,348
Non-current Assets    
Intellectual Property 4,643,099 5,078,060
Website development cost, net 3,187 4,250
Furniture and Equipment 16,065
Other Assets 38,132 46,560
Patent costs, net 86,614 98,987
Total non-current assets 4,787,097 5,227,857
Total Assets 4,817,993 5,229,205
Current Liabilities:    
Accounts payable 1,531,383 1,106,607
Accrued expenses 508,131 542,340
Accrued payroll and benefits 180,025 277,175
Convertible notes payable 56,259
Convertible notes payable to related party 400,000
Derivative liability 472,670 1,926,800
Other Liabilities
Total current liabilities 2,748,468 4,252,921
Total Liabilities 2,748,468 4,252,921
Commitments and Contingencies
Stockholders' Equity    
Common Stock $0.00001 par value, 450,000,000 shares authorized; 336,957,722 and 303,927,098 shares outstanding as of September 30, 2018 and September 30, 2017 respectively 3,370 3,040
Warrants 67
Additional paid-in capital 35,569,540 32,132,294
Accumulated deficit (33,530,848) (31,159,051)
Total Stockholders' Equity 2,069,526 976,283
Total Liabilities and Stockholders' Equity 4,817,993 5,229,205
Series A Preferred Stock [Member]    
Stockholders' Equity    
Preferred stock value 1,632
Series B Preferred Stock [Member]    
Stockholders' Equity    
Preferred stock value 25,615
Series C Preferred Stock [Member]    
Stockholders' Equity    
Preferred stock value $ 150